Investment Rating - The report maintains a positive outlook on strong domestic automotive brands, emphasizing the importance of complete vehicles, intelligent driving, and robotics for the year [6][8]. Core Viewpoints - The report highlights a sustained optimism for strong domestic automotive brands, with a focus on complete vehicles, intelligent driving, and robotics as key investment areas for the year [6][8]. - It anticipates a limited seasonal adjustment in Q2 2025, with a strong emphasis on investing in robust domestic brands and the robotics supply chain [7][8]. - The report suggests that the domestic market share of strong independent brands is expected to increase by 8-14%, with several brands projected to see significant opportunities for growth [7][8]. Market Tracking - The total insurance volume for the week of July 14-20 was 399,000 units, slightly below the 400,000 weekly threshold, with a year-on-year increase of 9% and a month-on-month increase of 8.1% [7][26]. - The report notes that the export volume in June reached 458,000 units, representing a year-on-year increase of 28% [7][26]. - The report indicates that the penetration rate of new energy vehicles reached 53.9%, with weekly insurance volume for new energy vehicles at 215,000 units, reflecting a year-on-year increase of 16% [7][30]. Industry Prosperity - The report tracks the industry’s prosperity through terminal data, orders, and export totals, indicating a general decline in orders during the second week of July [7][26]. - It highlights that the market share of independent brands has been steadily increasing, with a significant rise from 36% in January 2021 to 64% by December 2024 [38]. Key Stocks - The report emphasizes the importance of focusing on key stocks such as Xiaomi, Leap Motor, Xpeng, BYD, Seres, Geely, and Changan, with specific recommendations based on their market positions and product cycles [7][8]. - It identifies specific stocks with high potential for growth, particularly in the context of the ongoing transition towards electric vehicles and robotics [7][8].

Core Insights - The report emphasizes the complexity of investing in local government bonds, highlighting the need to understand pricing logic, regional differences, and market dynamics [6] - The entry of more trading institutions, such as wealth management subsidiaries and public funds, has significantly improved the liquidity of local government bonds, especially in the second half of last year [6] - The report expresses a cautious outlook for pure bond investments in the fourth quarter, citing potential market adjustments and increased volatility risks due to liquidity pressures from wealth management products [7] Summary by Sections Fund Manager Profile - Li Yulu, the fund manager of Manulife Fund, has a decade of experience in fixed income and holds a master's degree in international banking and monetary economics from the University of Birmingham [6] - Li has previously worked in various roles related to credit analysis and investment management before joining Manulife in 2021 [6] Investment Strategy - The report discusses the current allocation strategy, focusing on convertible bonds primarily in the banking and aquaculture sectors, with a positive outlook on their performance due to low PB valuations [7] - It also mentions a portion of the portfolio allocated to environmental and state-owned enterprise reform themes, driven by strong government intentions to reduce debt [7] Market Performance - The report indicates a favorable view on the overall performance of fixed income products, particularly convertible bonds, which align with current market trends [8] - It notes that the median returns of primary and secondary bond funds are similar this year, but primary bond funds have experienced less drawdown, making them more attractive to certain investors [8] Sector Focus - The report highlights significant changes in the holdings of actively managed equity funds, with a decrease in large-cap stocks and an increase in positions in industry leaders within the AI hardware and communication sectors [11][12] - It points out that the non-bank financial sector has seen substantial increases in holdings, reflecting a recovery in valuations and performance expectations [13] Investment Recommendations - The report suggests focusing on four main investment themes: communication and hardware sectors benefiting from AI expansion, non-bank financials, new consumption trends in Hong Kong, and defense and military sectors [14]

1. Report Industry Investment Rating - The report does not explicitly mention the overall industry investment rating 2. Core Viewpoints of the Report - In Q2 2025, the overall market value of A - share holdings of active equity - oriented funds decreased, while that of H - share holdings increased. The industry concentration of the top heavy - stock holdings of equity - oriented funds decreased. The communication, non - bank finance, and media industries saw significant increases in allocation ratios, while the steel, food and beverage, and coal industries had large reduction ratios [4][6]. - The structure of the top heavy - stocks of active equity - oriented funds changed. The overall number of large - market - cap leaders decreased, and the holdings of sub - industry leaders increased. The new high - growth technology stocks related to AI emerged, while traditional large - cap white - horse stocks were significantly reduced [4]. - In terms of industry leaders, the communication, non - bank finance, media, agriculture, forestry, animal husbandry, and beauty care industries were significantly increased, while the steel, coal, real estate, social services, and food and beverage industries were significantly reduced [21]. - The report suggests focusing on four investment themes: communication and hardware upstream under AI diffusion, non - bank finance, new consumption in the Hong Kong stock market, and national defense and military industry [26] 3. Summary by Relevant Catalogs 3.1 2025Q2 Active Fund Heavy - Stock Holding Structure Overview - **A - share and H - share holdings changes**: In Q2 2025, the total market value of active equity - oriented fund heavy - stock holdings was 1736.2 billion yuan, a 1.66% QoQ decrease. A - share holdings decreased by 2.79% QoQ to 1394.8 billion yuan, while H - share holdings increased by 3.20% QoQ to 341.3 billion yuan. Due to the complex macro - economic environment and market volatility, funds faced redemption pressure and tended to reduce large - cap stocks with poor liquidity [6]. - **Industry concentration decline**: From Q1 to Q2 2025, the industry concentration of the heavy - stock holdings of equity - oriented funds decreased. CR3 decreased by 0.56 percentage points to 38.37%, and CR5 decreased by 4.18 percentage points to 51.18%. The top five industries in terms of holding market value remained the same, but the proportion of the electronics industry increased, while the other four industries decreased [4][7]. - **Structural adjustment of industry holdings**: In Q2 2025, 12 industries saw an increase in the total market value of holdings. The communication, non - bank finance, and media industries had large increases in allocation ratios, rising by 75.88%, 64.62%, and 38.37% respectively. The steel, food and beverage, and coal industries had large reduction ratios, decreasing by 46.32%, 26.16%, and 23.99% respectively [9] 3.2 Q2 Active Fund Top Heavy - Stock Tracking - **Change in the structure of top heavy - stocks**: In Q2 2025, the structure of the top 20 heavy - stocks of active equity - oriented funds changed. The large - market - cap leaders decreased, and the sub - industry leaders increased. The market value of the top 20 heavy - stocks accounted for 20.72% of all heavy - stocks, a 2% decrease from Q1 [12]. - **Changes in the top five heavy - stocks**: The top five heavy - stocks remained the same, but the overall holdings decreased. New high - growth technology stocks such as New Fiber Optic Technology and Inphi Corporation quickly rose in the rankings, while traditional large - cap white - horse stocks such as Luxshare Precision Industry, Midea Group, and Contemporary Amperex Technology were significantly reduced [4]. - **Hong Kong stock market adjustment**: In the Hong Kong stock market, AI and Internet media leaders were reduced, while the pharmaceutical and new consumption sectors that performed well in Q2 were significantly increased [18] 3.3 Q2 Industry Leader Heavy - Stock Tracking - **Industry leader allocation changes**: In Q2 2025, the communication, non - bank finance, media, agriculture, forestry, animal husbandry, and beauty care industries were significantly increased, while the steel, coal, real estate, social services, and food and beverage industries were significantly reduced [21]. - **Communication industry focus**: Driven by the booming demand for AI hardware, the communication industry became the focus of funds. The optical module sector, which benefits from the expansion of AI capital expenditure, was the main area for increasing communication heavy - stocks. The profitability of communication equipment is expected to continue to improve in the second half of the year [22]. - **Non - bank finance sector highlights**: The leaders of the non - bank finance sector attracted attention. The holdings of Ping An Insurance and CPIC increased by 55% and 41% respectively, and securities leaders such as Citic Securities and Huatai Securities also saw over 30% increases. The brokerage sector's performance is expected to continue to improve [23] 3.4 Investment Recommendations - **AI diffusion - related communication and hardware upstream**: The significant increase in the holdings of optical module leaders reflects that funds are extending from AI software to computing infrastructure. AI capital expenditure is expected to drive the performance of upstream sectors in the second half of the year [26]. - **Non - bank finance sector**: The concentrated increase in holdings of leaders such as Citic Securities and Ping An Insurance reflects the positive expectations of the market for the profitability improvement of the brokerage and insurance sectors. The non - bank finance sector is expected to achieve a resonance of valuation repair and performance recovery [26]. - **Hong Kong stock new consumption theme**: After the correction in the AI sector, funds refocused on consumption structure highlights, especially in the Hong Kong stock market. Sub - sectors such as pets, toys, and emotional consumption have become important directions for heavy - stock allocation [26]. - **National defense and military industry safety theme**: The significant increase in the holdings of core military stocks reflects the high attention of institutions to the "national security + high - end manufacturing" theme. The military industry has policy support, order growth, and mid - report performance improvement expectations, with medium - term allocation value [27]

Core Viewpoints - The report maintains a positive outlook on the brokerage sector, emphasizing the relative return opportunities within the non-bank financial sector as the market transitions from a stock market to an incremental market since June 2025 [5][6]. Summary by Sections Market Dynamics - The A-share market has shifted to an incremental market, with trading activity increasing significantly. On July 22, 2025, the total transaction volume across three exchanges reached 1.93 trillion yuan, marking an 11.7% increase from the previous trading day. The margin financing and securities lending balance was 1.9 trillion yuan, up 0.8%, with financing purchases increasing by 7.6% [5]. Performance Forecast - For the first half of 2025, 29 brokerages that have announced profit forecasts expect a net profit growth rate of 75.02% year-on-year, with the second quarter projected to grow by 20.66%. The top five brokerages by profit growth include Huaxi Securities (1189.5%), Guolian Minsheng (1183.0%), and Guosheng Jin控 (315.5%) [6]. Regulatory and Business Innovations - The report highlights the potential benefits for brokerages from the upcoming stablecoin regulations in Hong Kong, effective August 1, 2025. Chinese brokerages are upgrading their virtual asset trading licenses, which could open new revenue streams through cryptocurrency trading commissions and stablecoin cross-border settlement [7]. Valuation Discrepancies - The report notes a significant valuation gap between H-shares and A-shares of brokerages. As of July 22, 2025, H-shares have increased by 73.9%, while A-shares have only risen by 22.0%, resulting in a 51.9% difference. The average price-to-book ratio for H-shares is 1.0, compared to 1.5 for A-shares, indicating potential for A-shares to catch up [7]. Market Sentiment and Fund Flows - The report discusses a shift in investor sentiment from a trading strategy to a holding strategy, suggesting that the current brokerage market rally may be slower but more sustainable. The implementation of policies aimed at promoting high-quality development in public funds is expected to attract more capital into the underweighted non-bank financial sector, benefiting brokerages [8]. Investment Recommendations - The report suggests focusing on leading brokerages and financial technology leaders that are likely to benefit from active market trading [9][10].

宏利基金李宇璐:纯债为基,增强为刃 证券研究报告/转债专题报告 2025年07月23日 分析师:吕品 执业证书编号:S0740525060003 Email: Ivpin@zts.com.cn 分析师:宋康泰 执业证书编号:S0740525070003 Email: songkt01@zts.com.cn | 重要指数收盘价及涨跌幅 | | | | --- | --- | --- | | 简称 | 收盘价 | 涨跌幅% | | 中证转债 | 459.59 | 0.02 | | 上证指数 0.02 | 3.581.86 | | 转债及相关指数走势对比 报告摘要 基金经理简介:李宇璐,固收部甚金经理;英国伯明翰大学国际银行货币学硕士;10 年固定收益从业经验,具有基金从业资格。2012年至 2014年任职于大公国际资信评 估有限公司工商企业二部担任分析师、行业组长;2015年任职于安邦保险集团股份有 限公司信用险部,担任信用评审经理;2016年3月加入建信养老金管理有限责任公 司投资管理部,担任信用研究员、投资经理助理及投资经理,18年起管理年金及养老 金产品:2021年4月加入泰达宏利固定收益部,担任甚金经理助 ...

Investment Rating - The report maintains an "Overweight" rating for the brokerage sector, indicating a positive outlook for relative returns in the industry [3][23]. Core Insights - The brokerage sector is expected to benefit from the transition of the A-share market from a stock market to an incremental market, with trading activity increasing significantly. As of July 22, 2025, the trading volume reached 1.93 trillion yuan, marking a 11.7% increase from the previous trading day [3][6]. - The forecasted net profit growth for the first half of 2025 for 29 brokerages is centered around 75.02%, with a notable 20.66% growth expected in the second quarter of 2025 [3][13]. - The report highlights the potential for brokerages to benefit from the upcoming regulatory changes regarding stablecoins and virtual asset licenses, which could open new revenue streams [7][12]. Summary by Sections Market Dynamics - The report notes that the brokerage sector has seen a significant performance gap between H-shares and A-shares, with H-shares increasing by 73.9% compared to a mere 22.0% for A-shares, indicating a potential for A-shares to catch up [7][16]. - The report identifies a shift in investor strategy from trading to holding, suggesting a more sustainable growth trajectory for the brokerage sector [7][12]. Performance Forecast - The top five brokerages by net profit forecast for 1H25 are: Guotai Junan (156.2 billion yuan, 212% growth), China Galaxy (65.82 billion yuan, 50% growth), and others, indicating strong performance across the sector [6][13]. - The report emphasizes that the brokerage sector is likely to attract more incremental capital as market sentiment shifts, particularly with the implementation of policies aimed at enhancing the quality of public funds [7][12]. Investment Recommendations - The report suggests focusing on leading brokerages such as Guotai Junan, CITIC Securities, and financial technology leaders like Dongfang Wealth, which are expected to benefit from increased market activity [7][12]. - The report also notes that the current valuation of H-shares remains attractive compared to A-shares, with an average price-to-book ratio of 1.0 for H-shares versus 1.5 for A-shares [7][16].

Investment Rating - The report maintains an "Overweight" rating for the brokerage sector [2] Core Viewpoints - The brokerage sector is expected to benefit from the transition of the A-share market from a stock market to an incremental market, with trading activity increasing and overall market valuations rising [5][6] - The forecasted net profit growth for the brokerage firms in the first half of 2025 is projected to be 75.02%, with significant contributions from leading firms [5][8] - The report highlights the potential for brokers to benefit from stablecoin developments and virtual asset license upgrades, which could create new growth opportunities [5] - There is a notable price discrepancy between A-shares and H-shares of brokerage firms, indicating potential for A-shares to catch up [5][9] - The report suggests that the current market environment is conducive for investing in underperforming brokerage stocks, with a focus on leading firms and fintech companies [5] Summary by Sections Industry Overview - The total number of listed companies in the brokerage sector is 83, with a total market value of 76,326.04 billion yuan and a circulating market value of 73,589.02 billion yuan [2] Market Dynamics - The A-share market has seen a significant increase in trading volume, with a transaction amount of 1.93 trillion yuan on July 22, 2025, marking an 11.7% increase from the previous trading day [5] - The financing balance in the market reached 1.9 trillion yuan, reflecting a 0.8% increase, while the financing purchase balance increased by 7.6% [5] Performance Forecast - The report indicates that 29 brokerage firms have forecasted a net profit growth of 75.02% for the first half of 2025, with the second quarter showing a 20.66% year-on-year growth [5][8] - The top five firms by net profit growth include Huaxi Securities (1189.5%), Guolian Minsheng (1183.0%), and Guosheng Jinkong (315.5%) [5][8] Investment Recommendations - The report recommends focusing on leading brokerage firms such as Guotai Junan, CITIC Securities, and Orient Securities, as well as fintech leaders like Dongfang Wealth and Zhinancun [5]

Investment Rating - The report maintains a "Buy" rating for the company [4] Core Views - The company is positioned as a leader in the ophthalmology sector, actively developing multiple next-generation products targeting retinal diseases, including gene therapies (KH631, KH658) and high-concentration Conbercept, focusing on long-acting treatments [6][9] - The global sales of Faricimab are projected to reach CHF 3.864 billion (approximately USD 4.4 billion) in 2024, reflecting a 68% year-on-year growth, indicating the commercial value of long-acting treatments for retinal diseases [6][9] - The company has a robust pipeline with significant advancements in gene therapy and other innovative drugs, which are expected to contribute to steady revenue growth in the coming years [6][18] Summary by Sections Section 1: Gene Therapy in Ophthalmology - The company is advancing gene therapies that show superior safety profiles compared to major competitors, with KH631 demonstrating a lower incidence of adverse effects in clinical trials [11][12] - The clinical data for KH631 indicates potential for over two years of dosing intervals, enhancing its market appeal [9][14] Section 2: Expansion into New Fields - The company is diversifying its portfolio with several new drugs in clinical trials outside of ophthalmology, including treatments for glioblastoma, postpartum depression, and pain management [18][19] - The innovative nature of these drugs positions the company favorably for international market opportunities [18][19]

Group 1: Overall Market Overview - The overall fund market is dominated by mixed funds, totaling 4,702, followed by bond funds and equity funds. The growth rate for equity funds in the current quarter is the highest at 7.45%, followed by REITs at 6.15%. The largest scale is in money market funds, reaching 142,311.36 billion yuan [3][4] - As of the end of Q2 2025, there are 581 ordinary equity funds, 1,359 flexible allocation funds, 26 balanced mixed funds, and 2,613 equity mixed funds. The number of equity mixed funds increased by 41 compared to Q1 2025 [3][4] Group 2: Active Equity Fund Positioning - The highest equity position is in ordinary equity funds at 89.61%, followed by 88.19% in equity mixed funds. The stock positions of various active equity funds are close to historical highs since 2015, with flexible allocation funds reaching their highest ever [4] - The highest industry allocation for active equity funds is in Hong Kong Stock Connect at 19.91%, followed by electronics at 15.07%. The allocation to Hong Kong Stock Connect has reached its highest level since Q1 2015 [4][5] Group 3: Stock and Individual Stock Configuration - The highest valued stock held by active equity funds is Tencent Holdings. Among the top twenty holdings, six are from Hong Kong Stock Connect, accounting for 33.79% of the total value of the top 20 stocks. The food and beverage and electronics sectors each have three stocks in the top holdings, accounting for 12.44% and 11.72%, respectively [4][5] - The stock with the highest increase in holdings is Zhongji Xuchuang, with an increase of 139.45 billion yuan. Other stocks with increases exceeding 100 billion yuan include Xinyi and Shunfeng Holdings, all from the communication sector [5]

Investment Rating - The report assigns an "Accumulate" rating for the company, marking the first coverage [2][10]. Core Insights - The report highlights the focus on innovative antibacterial treatments, particularly the commercialization of the core product, Contizole, and the ongoing development of its pipeline products [8][9][11]. - The company is positioned in the growing market of antibiotic resistance, with a strong emphasis on addressing clinical challenges through differentiated innovation [13][20]. Financial Forecast and Valuation - Projected revenues for the company from 2025 to 2027 are estimated at 1.74 billion, 2.05 billion, and 2.49 billion CNY respectively, reflecting a growth trajectory despite initial cash flow delays typical of biotech firms [10][46]. - The report utilizes a DCF valuation method, indicating that the current market valuation is relatively undervalued based on the company's growth potential and market position [10][21]. Business Overview - The company has established a solid domestic business foundation, with its core product, Contizole, showing significant sales growth of 88.3% in 2023 and projected continued growth of 43.51% in 2024 [4][27]. - The company has expanded its hospital coverage to 582 hospitals, with 150 hospitals formally approved for bulk procurement, enhancing market penetration [4][27]. Pipeline Development - The report details the ongoing global Phase III clinical trials for MRX-4, which is aimed at treating diabetic foot infections, and highlights the successful completion of Phase I trials for MRX-5 and MRX-8 [7][41][43]. - The company is actively pursuing international clinical development for its innovative products, with MRX-5 receiving FDA orphan drug designation, indicating strong potential for market entry [7][41][43]. Competitive Positioning - The company is strategically positioned in the antibacterial sector, focusing on multi-drug resistant bacteria, and has developed a comprehensive product matrix to address various infection types [20][21]. - The innovative approach includes a dual coverage strategy for Gram-positive and Gram-negative bacteria, enhancing its competitive edge in the market [9][20].